Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.7350
-0.0200 (-2.65%)
At close: Apr 1, 2025, 4:00 PM
0.7632
+0.0282 (3.84%)
After-hours: Apr 1, 2025, 4:47 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $60.77 million as of April 1, 2025. Its market cap has decreased by -63.87% in one year.
Market Cap
60.77M
Enterprise Value
-96.64M
1-Year Change
-63.87%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $60.77M, a decrease of -79.86%. That is a compound annual growth rate of -29.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 62.43M | -21.25% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |